People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tetra Discovery Partners, Inc. | — | Biotechnology | Series B | $40.5M | $1.4B | 2016 |
| Beryllium, LLC | — | Pharmaceuticals | Series A | $11.5M | $232.3M | 2009 |
Lance Stewart at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lance Stewart on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Donald Parfet | 1 | 5 |
| Paul D'Amato | 1 | 4 |
| Brian Hubbard | 1 | 4 |
| Douglas Morton | 1 | 3 |
| Mirza Cifric | 1 | 3 |
| Jeffrey Newton | 1 | 3 |
| Neil Weir | 1 | 2 |
| Mark Gurney | 1 | 1 |
| Joseph Collard | 1 | 1 |
| Brent Bannerman | 1 | 1 |
| Johan Pontin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.